Expression of MiR-429 in Patients with Acute Lymphoblastic Leukemia and Its Prognostic Value.
10.7534/j.issn.1009-2137.2020.01.020
- Author:
Li-Cui ZHANG
1
;
Chen ZHONG
2
;
Ya-Jing MA
1
;
Min LIU
1
;
Wei-Xia NONG
3
Author Information
1. Department of Clinical Laboratorial Examination, The First Affiliated Hospital of Medical College of Shihezi University, Shihezi 832008, Xinjiang Uygur Autonomous Region, China.
2. Third Department of General Surgery, The First Affiliated Hospital of Medical College of Shihezi University, Shihezi 832008, Xinjiang Uygur Autonomous Region, China.
3. Department of Hematology, The First Affiliated Hospital of Medical College of Shihezi University, Shihezi 832008, Xinjiang Uygur Autonomous Region, China,E-mail:2557291951@qq.com.
- Publication Type:Journal Article
- From:
Journal of Experimental Hematology
2020;28(1):119-124
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To analyze the expression level of miR-429 in patients with acute lymphoblastic leukemia(ALL) and its clinical prognostic value.
METHODS:One hundred and Twenty-six patients with ALL treated in our hospital from April 2016 to February 2018 were selected, and 100 healthy persons in the same period were selected as control group. Bone marrow mononuclear cells were collected. The expression level of miR-429 in bone marrow mononuclear cells was detected by RT-PCR, and the correlation of miR-429 expression with clinical characteristics and therapeutic efficacy was analyzed. Kaplan-Meier method and multi-factorial Cox regression model were used to analyze the correlation between the level of microRNA-429 and the prognosis of ALL patients.
RESULTS:The relative level of miR-429 in ALL patients was 2.47±0.07, which was signifi-cantly higher than that in control group (P<0.05). The level of miR-429 significantly correlated with the leucocyte level（r=0.994）, LDH（r=0.992）, the ratio of bone marrow primordial cells（r=0.995） and risk grade of ALL patients（r=0.991). The level of miR-429 not correlate with the age, sex, Hb level, Plt level and immunophenotype of ALL patients (P>0.05). The level of miR-429 was not significantly different between CR patients and control group (P>0.05); the level of miR-429 in PR patients was higher than that in control group and CR patients (P<0.05). The level of miR-429 in NR patients was higher than that in other groups (P<0.05). Kaplan-Meier survival analysis showed that the overall survival rate of ALL patients with low expression of miR-429 was better than that of ALL patients with high expression of miR-429 (P<0.05). Univariate Cox regression analysis showed that leukocyte level, ratio of bone marrow primordial cells, Hb and LDH level, risk grading and miR-429 were the factors influencing overall survival rate in ALL patients (P<0.05). Multivariate Cox regression analysis showed that leukocyte level, ratio of bone marrow primordial cells, risk grading, and miR-429 were the factors influencing overall survival rate (P<0.05).
CONCLUSION:The expression of miR-429 is high in ALL patients, which closely relates to the curative effect and pro-gnosis of ALL patients, and can be used as a reference index for evaluation of clinical prognosis of ALL patients.
